Pharma and Healthcare Insight provides pharma market intelligence, trend analysis, forecasts and company profiles for the pharma industry on a country-by-country basis across North and South America, Central, Eastern and Western Europe, Asia, the Middle East and Africa. It gives access to the latest independent analysis of market data for the global pharma industry as well as a searchable archive of past articles and data.
ยป To access our 
RSS feed of headlines copy this link to your RSS reader
Industry / Brazil
Brazilian multi-brand consumer goods-maker Hypermarcas has again increased its exposure to the pharmaceutical sector, announcing the signing of a memorandum of understanding to acquire over-the-counter (OTC) medicine manufacturer Luper Pharmaceutical Industry for BRL52.1mn (US$29.5mn). Hypermarcas states the acquisition complements its portfolio of branded generics and OTC products....
2010-03-15Industry / Brazil
Brazil's Regulatory Board of the Medicine Market, CMED, has authorised an average 4.6% increase in the maximum price of medicines as part of its annual price review for 2010. Three...
2010-03-12Industry / United States
It is BMI's Pharmaceuticals and Healthcare team's view that personalised medicines - defined as the use of information about a person's genes to prevent, diagnose and treat a disease...
2010-03-12Industry / Australia
Asia Pacific's respect for intellectual property rights with regard to medicine has improved marginally over the past 12 months, according to the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 to the United States Trade Representative (USTR). The Philippines and Australia have been upgraded to 'Priority Watch' and 'Watch List' countries...
2010-03-09Industry / India
Aurobindo Pharma has a launched a new division that will provide dedicated contract research and manufacturing services (CRAMS). AuroSearch is targeting large and small biopharmaceutical...
2010-03-08Industry / India
BMI believes Bangalore-based Strides Arcolab's impressive growth trajectory is set to continue. The drugmaker operates from a low-cost base, is present in over 60 developed states...
2010-03-05Industry / Estonia
BMI believes that the use of generic drugs in Estonia is set to increase, following the introduction of a decree aimed at promoting the substitution of generics for prescription drugs. Building on current requirements for doctors to prescribe medicines by their international non-proprietary name (INN) rather than a brand name, the new directive means that pharmacists have to offer...
2010-03-18Industry / Russia
Pharmaceutical prices in Russia and Ukraine have been under intense scrutiny since the latter part of 2008, as a result of negative economic conditions, associated currency devaluations...
2010-03-17Industry / Lithuania
BMI believes Lithuania's pricing and reimbursement environment is becoming increasingly negative for major pharmaceutical companies and patients. A Government of the Republic of Lithuania...
2010-03-16Industry / Jordan
According to the CEO of Jordan's Hikma Pharmaceuticals, the firm will continue to reject any takeover offers until it reaches a market value of US$7.7bn. This stance is in line with its recent history during which the firm has refused seven approaches during the last three years. Even then, the prospect of selling is unlikely to happen immediately as the CEO's family owns a 31%...
2010-03-18Industry / Canada
Canadian drugmaker Paladin Laboratories has entered the South African pharmaceutical market with the acquisition of 34.99% of Pharmaplan. Pharmaplan is a South African importer and...
2010-03-18Industry / Ghana
The introduction of Ghana's National Health Insurance Scheme (NHIS) during 2003-2004 was intended to give more autonomy to drug purchases across the country. As of 2003, public health...
2010-03-17Industry / Sweden
BMI's Burden of Disease Database (BoDD) records the number of disability-adjusted life years (DALYs) that are lost as a result of having or having had a disease. Therefore, our measure of DALYs is a measure of lost productivity. According to the BoDD, Sweden will become a healthier country over the next twenty years, with the number of disability-adjusted life years (DALYs) lost...
2010-03-17Industry / Germany
Germany's new centre-right coalition government, formed after the September 2009 elections, has pledged to reform the country's healthcare system, though there are disagreements between...
2010-03-17Industry
The latest PhRMA submission to the upcoming 2010 Special 301 report by the US Trade Representative (USTR) holds mixed results for countries from Western Europe. Italy has been placed...
2010-03-16
